Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Loxo Oncology Inc (LOXO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Loxo Oncology Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Loxo Oncology Inc historical data, for real-time data please try another search
234.66 0.00    0.00%
14/02 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 234.66 - 234.88
Loxo Oncology Inc 234.66 0.00 0.00%

LOXO User Rankings

 
Users ranking according to the performance of their sentiments for the Loxo Oncology Inc stock.
RankUsernameTotalClosedWinningWin %Chg. %
1Lakshya Mehta111100+69%
2Hemant Joshi111100+68.97%
3Charles Brandon111100+68.96%
4Michal Cabarka111100+68.93%
5Alex Chiah111100+68.91%
6Surya Kuchibhotla111100+68.84%
7Alessandro Galimberti111100+56.81%
8Reuben Vaida111100+55.02%
9davide garulli22150+48.43%
10andriy pohors111100+48.26%
11cc pp111100+48.17%
12Bill ODell22150+8.6%
13אריאל הלוי111100+7.75%
14Antonio Villalta Luna111100+2.31%
15vbg99111100+1.77%
16Pico Paci111100+0.77%
17Abbas Reza111100+0.56%
18Nacho Hernandez111100+0.37%
19fahad ibrahim111100+0.34%
20Oded Henin11000%
21hank hsu11000%
22Kevin Coyne11000%
23Pierre renaud11000%
24Lk Lo1100-0.4%
25Narendra Lakhani1100-0.63%
26Иван Гансович1100-1.01%
27alex averbuch1100-2.14%
28Aa Ff1100-48.54%
29Göran Elmberger1100-49.16%
30Vilem Cerny1100-49.2%
31d andres calvo1100-49.53%
32Michal Miko1100-50.26%
33Ivan Dimitrov1100-52.29%
34Erik Esparza22150-52.56%
35Mohamed Ibrahim seddik1100-52.66%
36Tomáš Jaroš44375-54.14%
37Angel Fernandez1100-54.47%
38Angel Fernandez1100-57.36%
39primo fulvi1100-57.4%
40Ever Maldonado Ospino1100-59.96%
41Michal Palka1100-68.85%
42Ali Amin Akbari1100-68.85%
43מישה כהן1100-68.86%
44Malcom Gravel1100-68.87%
45Udovin Viktor1100-68.88%
46Aldo Andrade1100-68.91%
47Dogukan ALp1100-68.92%
48Sekar Marimuthu1100-68.93%
49William Modesti1100-68.95%
50Δημήτρης Βολικάκης1100-68.96%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LOXO Comments

Write your thoughts about Loxo Oncology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sekar Marimuthu
Sekar Marimuthu Jan 07, 2019 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why it's increased
Leonid Agureev
Leonid Agureev Jan 07, 2019 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lilly to buy Loxo Oncology in $8 billion cancer push
Sekar Marimuthu
Sekar Marimuthu Jan 07, 2019 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
thanks
Sekar Marimuthu
Sekar Marimuthu Jan 07, 2019 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes I have seen
Mi Michal
Mi Michal Nov 02, 2018 7:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They will get FDA for their drug Larotrectinib before November 26!! And the drug is amazingly efficient! Loxo will get!!!
Sekar Marimuthu
Sekar Marimuthu Nov 02, 2018 7:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good
Sekar Marimuthu
Sekar Marimuthu Nov 02, 2018 7:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ur genius
Nick LaRue
Nick LaRue Dec 19, 2017 1:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock is going to ****up this year
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email